当前位置:
X-MOL 学术
›
Microbiology Australia
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
CSL, from blood stock to blue chip
Microbiology Australia Pub Date : 2020-10-16 , DOI: 10.1071/ma20050 Ian D Gust
中文翻译:
CSL,从血液库存到蓝筹股
更新日期:2020-10-17
Microbiology Australia Pub Date : 2020-10-16 , DOI: 10.1071/ma20050 Ian D Gust
From its modest beginning in 1916 with a staff of 20, CSL has grown into a major company, which now employs more than 25,000 people, operates in more than 70 countries and has a market capitalization of over A$130 billion.
中文翻译:
CSL,从血液库存到蓝筹股
CSL从1916年成立之初,只有20名员工,如今已发展成为一家大型公司,目前在全球70多个国家拥有25,000多名员工,拥有超过1300亿澳元的市值。